Phil has over 20 years of corporate tax advisory experience including over 10 years with KPMG and prior to that over 5 years working in industry with AstraZeneca. Phil currently serves as a director in KPMG’s global transfer pricing services practice, where he is responsible for quality and technical excellence on the UK firm’s transfer pricing engagements.
